Cell Therapy News/Articles, page-6191

https://www.forbes.com/sites/alexknapp/2020/08/27/the-inside-story-of-biotechs-barnum-and-his-covid-cures/#1556de62208a

Please check this link you will find this as below...

The third weapon NantKwest and ImmunityBio are developing to combat Covid-19 involves the use of mesenchymal stem cells, which are derived from bone marrow. This type of stem cell has been investigated over the past decade for diseases—like Covid-19—that can cause the body’s immune system to go into overdrive and attack itself. This treatment would be for the most severely sick Covid-19 patients, who are experiencing a “cytokine storm,” in which the immune system overreacts. Small-scale studies have suggested this might be an effective treatment, and several companies, including Melbourne, Australia–based Mesoblast, are already in late-stage clinical trials for severe Covid-19 patients. Soon-Shiong’s companies are working with hospitals to recruit patients for human trials.